Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.

Metabolon is a company developing metabolomics analytical methods and software for biomarker discovery

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases. The company was founded in 2016 by Nikole Kimes PhD.

A software solutions company providing bioinformatics solutions to life science and other sector

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat diseases linked to imbalances in the intestinal microbiome.

Biocrates Life Sciences AG is an Innsbruck-based medical diagnostics company focused on metabolomic research and technology.

CosmosID is a microbial genomics platform focused on characterization of microorganisms, pathogens and anti-microbial resistance for infectious disease identification, food safety inspections, pharmaceutical discovery, public health surveillance and microbiome analysis.

EnteroBiotix is a fecal microbiota transplantation founded in 2017 by James McIlroy.

Microbiotica Limited is a gut Bacteria Phenotype to Biomarker/Therapeutics founded in 2016 by Mike Romanos.

Microba Life Sciences Limited is a company founded in 2018 by Gene Tyson.

PharmaBiome is a microbiome company.

Arranta Bio is a company founded in 2019.

EverImmune is a microbial Immunotherapy founded in 2016.

MyBiotics Pharma is a company founded by Didi Daboush.

Clinical-Microbiomics is an independent contract research organization fully dedicated to microbiome research.

MicroSintesis is a Canada-based company.